Plantibodies, also known as plant-derived antibodies, are an emerging class of biologics that are produced from plants. They are composed of recombinant protein fragments, which are generated from plant expression systems. Plantibodies have a number of advantages over traditional animal-sourced antibodies. They are cost-effective and easier to manufacture, as they do not require animal serum, and they are also less likely to cause adverse reactions in patients due to their low immunogenicity. Plantibodies are also highly stable and can be produced at high yields, making them an attractive alternative to traditional antibodies. Plantibodies have been studied for a variety of therapeutic and diagnostic applications, such as cancer immunotherapies, infectious disease diagnostics, and allergy treatments. In addition, they are also being developed for use in vaccines and crop protection, making them a versatile and promising tool for medical and agricultural research.
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States